A detailed history of Adirondack Trust CO transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 880 shares of CLPT stock, worth $9,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
880
Previous 880 -0.0%
Holding current value
$9,864
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 05, 2022

BUY
$7.8 - $11.6 $3,978 - $5,916
510 Added 137.84%
880 $9,000
Q4 2021

Jan 13, 2022

BUY
$11.08 - $18.86 $4,099 - $6,978
370 New
370 $4,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $275M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.